Compare NNNN & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | SVC |
|---|---|---|
| Founded | 2021 | 1995 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 1995 |
| Metric | NNNN | SVC |
|---|---|---|
| Price | $11.49 | $8.57 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 43.0K | ★ 9.2M |
| Earning Date | 04-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.67% |
| EPS Growth | N/A | ★ 26.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,814,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.39 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.50 | $1.13 |
| 52 Week High | $55.65 | $8.92 |
| Indicator | NNNN | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 26.28 | 96.41 |
| Support Level | $10.50 | $1.62 |
| Resistance Level | $30.21 | N/A |
| Average True Range (ATR) | 1.95 | 0.11 |
| MACD | -0.03 | 0.70 |
| Stochastic Oscillator | 4.22 | 96.11 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.